Terms: = Sarcomas AND CHEK2, bA444G7, 11200, ENSG00000183765, O96017, RAD53, RP11-436C9_1, PP1425, LFS2, CHK2, HuCds1
36160 results:
1. Intralesional leiomyosarcoma malignant transformation from a biopsied benign angioleiomyoma of the proximal anterior tibia.
Ward TRW; Eastley NC; Sheikh N; Ashford RU
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782435
[TBL] [Abstract] [Full Text] [Related]
2. Immunotherapy in Sarcoma: Current Data and Promising Strategies.
Wood GE; Meyer C; Petitprez F; D'Angelo SP
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557
[TBL] [Abstract] [Full Text] [Related]
3. Targeted PLK1 suppression through RNA interference mediated by high-fidelity Cas13d mitigates osteosarcoma progression via TGF-β/Smad3 signalling.
Yuan Y; Cao D; Zhang A; Liu Z; Deng Z; Zhang S
J Cell Mol Med; 2024 May; 28(10):e18400. PubMed ID: 38780513
[TBL] [Abstract] [Full Text] [Related]
4. Acinic cell Carcinoma with high-grade Squamoglandular and Chondrosarcomatous Transformation Mimicking 'Carcinosarcoma ex-pleomorphic Adenoma': A Wrinkle in the Proposed Nomenclature Revision for Sarcomatoid Salivary Gland Neoplasms.
Rammal R; Batson B; Spector ME; Chiosea SI; Seethala RR
Head Neck Pathol; 2024 May; 18(1):44. PubMed ID: 38775845
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
[TBL] [Abstract] [Full Text] [Related]
6. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER.
Yang P; Zhang G; Zhang Y; Zhao W; Tang J; Zeng S; Lv X; Lv L
Radiat Oncol; 2024 May; 19(1):59. PubMed ID: 38773616
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
[TBL] [Abstract] [Full Text] [Related]
8. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
[TBL] [Abstract] [Full Text] [Related]
9. Optimized new Shengmai powder inhibits myocardial fibrosis in heart failure by regulating the rat sarcoma/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular regulated protein kinases signaling pathway.
Zeyu Z; Zhuangzhuang J; Yuwei S; Xuan Z; Ci W; Shuai W; Peipei Z; Qiuan R; Xianliang W; Jingyuan M
J Tradit Chin Med; 2024 Jun; 44(3):448-457. PubMed ID: 38767628
[TBL] [Abstract] [Full Text] [Related]
10. TCF12 Transcriptionally Activates SPHK1 to Induce Osteosarcoma Angiogenesis by Promoting the S1P/S1PR4/STAT3 Axis.
Li W; Liu J; Cai T; Hu X
Mol Cell Biol; 2024; 44(5):178-193. PubMed ID: 38767243
[TBL] [Abstract] [Full Text] [Related]
11. HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?
Becker AK; Puladi B; Xie K; Cassataro A; Götzl R; Hölzle F; Beier JP; Knüchel-Clarke R; Braunschweig T
World J Surg Oncol; 2024 May; 22(1):131. PubMed ID: 38760830
[TBL] [Abstract] [Full Text] [Related]
12. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.
Mousavi SE; Najafi M; Aslani A; Fazlollahi A; Yekta Z; Sadri M; Nejadghaderi SA
Sci Rep; 2024 May; 14(1):11294. PubMed ID: 38760399
[TBL] [Abstract] [Full Text] [Related]
13. PARP1-DNA co-condensation: the driver of broken DNA repair.
Wei X; Zhou F; Zhang L
Signal Transduct Target Ther; 2024 May; 9(1):135. PubMed ID: 38760366
[TBL] [Abstract] [Full Text] [Related]
14. Glycolic acid and D-lactate-putative products of DJ-1-restore neurodegeneration in FUS - and SOD1-ALS.
Pal A; Grossmann D; Glaß H; Zimyanin V; Günther R; Catinozzi M; Boeckers TM; Sterneckert J; Storkebaum E; Petri S; Wegner F; Grill SW; Pan-Montojo F; Hermann A
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38760174
[TBL] [Abstract] [Full Text] [Related]
15. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
[TBL] [Abstract] [Full Text] [Related]
16. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
[TBL] [Abstract] [Full Text] [Related]
17. Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
Gargett T; Truong NTH; Gardam B; Yu W; Ebert LM; Johnson A; Yeo ECF; Wittwer NL; Tapia Rico G; Logan J; Sivaloganathan P; Collis M; Ruszkiewicz A; Brown MP
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754916
[TBL] [Abstract] [Full Text] [Related]
18. Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.
Nasri E; Torrence DE; Vasilopoulos T; Knapik JA; Lagmay JP; Reith JD; Gibbs CP
Cancer J; 2024 May-Jun 01; 30(3):133-139. PubMed ID: 38753746
[TBL] [Abstract] [Full Text] [Related]
19. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
[TBL] [Abstract] [Full Text] [Related]
20. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract] [Full Text] [Related]
[Next]
